Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 4
1971 1
1977 2
1979 2
1980 2
1981 6
1982 3
1983 1
1984 8
1985 6
1986 17
1987 13
1988 10
1989 23
1990 20
1991 22
1992 17
1993 23
1994 37
1995 29
1996 41
1997 24
1998 40
1999 39
2000 43
2001 57
2002 59
2003 61
2004 91
2005 91
2006 100
2007 98
2008 109
2009 137
2010 174
2011 223
2012 254
2013 270
2014 315
2015 409
2016 430
2017 431
2018 492
2019 571
2020 756
2021 850
2022 773
2023 844
2024 946
2025 921
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,847 results

Results by year

Filters applied: . Clear all
Page 1
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC.
Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Yang JC, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Şendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Passaro A, Kim SW, Gadgeel SM, Xie J, Sun T, Martinez M, Ennis M, Fennema E, Daksh M, Millington D, Leconte I, Iwasawa R, Lorenzini P, Baig M, Shah S, Bauml JM, Shreeve SM, Sethi S, Knoblauch RE, Hayashi H; MARIPOSA Investigators. Cho BC, et al. Among authors: nguyen d. N Engl J Med. 2024 Oct 24;391(16):1486-1498. doi: 10.1056/NEJMoa2403614. Epub 2024 Jun 26. N Engl J Med. 2024. PMID: 38924756 Clinical Trial.
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.
Leighl NB, Akamatsu H, Lim SM, Cheng Y, Minchom AR, Marmarelis ME, Sanborn RE, Chih-Hsin Yang J, Liu B, John T, Massutí B, Spira AI, Lee SH, Wang J, Li J, Liu C, Novello S, Kondo M, Tamiya M, Korbenfeld E, Moskovitz M, Han JY, Alexander M, Joshi R, Felip E, Voon PJ, Danchaivijitr P, Hsu PC, Silva Melo Cruz FJ, Wehler T, Greillier L, Teixeira E, Nguyen D, Sabari JK, Qin A, Kowalski D, Şendur MAN, Xie J, Ghosh D, Alhadab A, Haddish-Berhane N, Clemens PL, Lorenzini P, Verheijen RB, Gamil M, Bauml JM, Baig M, Passaro A; PALOMA-3 Investigators. Leighl NB, et al. Among authors: nguyen d. J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10. J Clin Oncol. 2024. PMID: 38857463 Free PMC article. Clinical Trial.
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading.
Qdaisat S, Wummer B, Stover BD, Zhang D, McGuiness J, Weidert F, Chardon-Robles J, Grippin A, DeVries A, Zhao C, Marconi C, Karachi A, Xie C, Jobin G, Liu R, Michel S, Ma X, Moor RSF, von Roemeling C, Nguyen DT, Elliott L, Thomas N, Barpujari A, Geffrard H, Campaneria Y, Ogando-Rivas E, Rabideau C, Soni D, Huang J, Carrera-Justiz S, Fredenburg K, Silver NL, Sawyer WG, Rahman M, Ligon JA, Flores CT, Lee JH, Mitchell DA, Castillo P, Mendez-Gomez HR, Sayour EJ. Qdaisat S, et al. Among authors: nguyen dt. Nat Biomed Eng. 2025 Sep;9(9):1437-1452. doi: 10.1038/s41551-025-01380-1. Epub 2025 Jul 18. Nat Biomed Eng. 2025. PMID: 40681861
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
Yang JC, Lu S, Hayashi H, Felip E, Spira AI, Girard N, Kim YJ, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Passaro A, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Şendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Kim SW, Gadgeel SM, Owen S, Xie J, Sun T, Mehta J, Venkatasubramanian R, Ennis M, Fennema E, Daksh M, Roshak A, Man J, Knoblauch RE, Bauml JM, Baig M, Shah S, Sethi S, Cho BC; MARIPOSA Investigators. Yang JC, et al. Among authors: nguyen d. N Engl J Med. 2025 Oct 30;393(17):1681-1693. doi: 10.1056/NEJMoa2503001. Epub 2025 Sep 7. N Engl J Med. 2025. PMID: 40923797 Clinical Trial.
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery.
Chen AXY, Yap KM, Kim JS, Sek K, Huang YK, Dunbar PA, Wiebking V, Armitage JD, Munoz I, Todd KL, Derrick EB, Nguyen D, Tong J, Chan CW, Hoang TX, Audsley KM, van Elsas MJ, Middelburg J, Lee JN, de Menezes MN, Cole TJ, Li J, Scheffler C, Scott AM, Mackay LK, Waithman J, Oliaro J, Harrison SJ, Parish IA, Lai J, Porteus MH, House IG, Darcy PK, Beavis PA. Chen AXY, et al. Among authors: nguyen d. Nature. 2025 Aug;644(8075):241-251. doi: 10.1038/s41586-025-09212-7. Epub 2025 Jul 2. Nature. 2025. PMID: 40604285 Free PMC article.
Nanofabrication for Nanophotonics.
Yang Y, Jeon Y, Dong Z, Yang JKW, Haddadi Moghaddam M, Kim DS, Oh DK, Lee J, Hentschel M, Giessen H, Kang D, Kim G, Tanaka T, Zhao Y, Bürger J, Maier SA, Ren H, Jung W, Choi M, Bae G, Chen H, Jeon S, Kim J, Lee E, Kang H, Park Y, Du Nguyen D, Kim I, Cencillo-Abad P, Chanda D, Jing X, Liu N, Martynenko IV, Liedl T, Kwak Y, Nam JM, Park SM, Odom TW, Lee HE, Kim RM, Nam KT, Kwon H, Jeong HH, Fischer P, Yoon J, Kim SH, Shim S, Lee D, Pérez LA, Qi X, Mihi A, Keum H, Shim M, Kim S, Jang H, Jung YS, Rossner C, König TAF, Fery A, Li Z, Aydin K, Mirkin CA, Seong J, Jeon N, Xu Z, Gu T, Hu J, Kwon H, Jung H, Alijani H, Aharonovich I, Kim J, Rho J. Yang Y, et al. Among authors: du nguyen d. ACS Nano. 2025 Apr 8;19(13):12491-12605. doi: 10.1021/acsnano.4c10964. Epub 2025 Mar 28. ACS Nano. 2025. PMID: 40152322 Review.
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial.
Feagan BG, Sands BE, Siegel CA, Dubinsky MC, Longman RS, Sabino J, Laurent O, Luo A, Lu J, Nguyen DD, Muñoz-Elias EJ, Llewellyn H, Wang Y, Jang I, Bilsborough J, Marchelletta R, Towfic F, Yen M, Anderson JK, DuVall A, Kierkus J, Woynarowski M, Al Kharrat H, Targan SR, McGovern DPB. Feagan BG, et al. Among authors: nguyen dd. Lancet Gastroenterol Hepatol. 2025 Aug;10(8):715-725. doi: 10.1016/S2468-1253(25)00071-8. Epub 2025 May 30. Lancet Gastroenterol Hepatol. 2025. PMID: 40456235 Clinical Trial.
1-Hydroxy-1H-benzo[d][1,2,6]oxazaborinin-4(3H)-one.
Sarina EA, Olmstead MM, Nguyen DN, Groziak MP. Sarina EA, et al. Among authors: nguyen dn. Acta Crystallogr C. 2013 Feb;69(Pt 2):183-5. doi: 10.1107/S0108270113000681. Epub 2013 Jan 16. Acta Crystallogr C. 2013. PMID: 23377688
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.
Drizyte-Miller K, Engstrom LD, Klomp JA, Stalnecker CA, Stamey AG, Taylor KE, Roach MK, Robb R, Waters LM, Calinisan A, Degan S, Chang WH, Helu XM, Nguyen D, Baldelli E, Pierobon M, Petricoin EF, Briere DM, Hallin J, Christensen JG, Bryant KL, Cox AD, Olson P, Der CJ. Drizyte-Miller K, et al. Among authors: nguyen d. Cancer Res. 2025 Sep 15;85(18):3540-3557. doi: 10.1158/0008-5472.CAN-25-1507. Cancer Res. 2025. PMID: 40694535
8,847 results